Rapid diagnosis and follow up of bladder cancer patients using urinary high molecular weight cytokeratins

World Journal of Urology

Volumn 24, Issue 3, 2006, Pages 345-352

  Attallah, Abdelfattah M ^a   Sakr, Hanem A ^b   Ismail, Hisham ^a   Ismail, Mohamed F ^c   Ibrahim, Ashraf S ^a   El Sharabasy, Mohamed M ^c   El Dosoky, Ibrahim ^b  

^a Biotechnology Research Center of New Damietta   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c Mansoura University   (Egypt)

Author keywords

Bladder cancer; CK1K10 monoclonal antibody; Cytokeratins; Dot EIA; Tumor marker; Urine

Indexed keywords

KERATIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PATHOLOGY; URINE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 33746499659     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-006-0100-4     Document Type: Article

References (40)

1. Andreadis C, Touloupidis S, Galaktidou G et al (2005) Serum CYFRA 21-1 in patients with invasive bladder cancer and its relevance as a tumor marker during chemotherapy. J Urol 174(5):1771-1775
2. Attallah AM, el-Didi M, Seif F et al (1996) Comparative study between cytology and dot-ELISA for early detection of bladder cancer. Am J Clin Pathol 105(1):109-114
3. Attallah AM, Helmi H, el-Helali E et al (1991) A dipstick, dot-ELISA assay for the rapid and early detection of bladder cancer. Cancer Detect Prev 15(6):495-499
4. Attallah AM, Sakr H, Ismail H et al (2005) Office-based immunodiagnostic assay for the detection of a urinary nuclear matrix protein 52 in bladder cancer patients. Br J Urol Int 96(3):334-339
5. Bennink R, Van Poppel H, Billen J et al (1999) Serum tissue polypeptide antigen (TPA): Monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer. Anticancer Res 19:2609-2613
6. Clayman RV, Reddy P, Lange PH (1984) Flexible fiberoptic and rigid-rod lens endoscopy of the lower urinary tract: A prospective controlled comparison. J Urol 131:715-716
7. Dey P (2004) Urinary markers of bladder carcinoma. Clin Chim Acta 340:57-65
8. El-Mawla NG, el-Bolkainy MN, Khaled HM (2001) Bladder cancer in Africa update. Semin Oncol 28(2):174-178
9. Fetissof F, Serres G, Haillot O (1990) Cytokeratins and transitional epithelium of the bladder. Particular distribution of cytokeratins. Arch Anat Cytol Pathol 38:159-162
10. Friedrich MG, Hellstern A, Toma MI et al (2003) Are false positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?. Eur Urol 43:146-151
11. Fuchs E (1988) Keratins as biochemical markers of epithelial differentiation. Trends Genet 4:277-281
12. Gordon MJ, Lee KJ, Arias AA et al (1991) Protocol for resolving protein mixtures in CZE. Anal Chem 63:69-72
13. Grossman HB (1998) New methods for detection of bladder cancer. Semin Urol Oncol 16:17-22
14. Herr HW, Shipley WU, Bajorin DF (2001) Cancers of the genitourinary system. In: DeVita VT, Hellman S, RosenbergPSA (eds) Cancer: principles & practice of oncology. Lippincott Williams & Wilkins, Philadelphia, pp 1396-1418
15. Jemal A, Thomas A, Murray T et al (2002) Cancer statistics, 2002. CA Cancer J Clin 52(1):23-47
16. Jiang J, Ulbright TM, Younger C et al (2001) Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Arch Pathol Lab Med 125(7):921-923
17. Hakenberg OW, Fuessel S, Richter K et al (2004) Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma. Urology 64(6):1121-1126
18. Khanna OP, Wu B (1987) Tissue polypeptide antigen (TPA) as a predictor for genitourinary cancers and their metastases. Urology 30:106-110
19. Laemmli UK (1970) Cleavage of structure of proteins during assembly of the head of the bacteriophage T4. Nature 277:680-685
20. Lokeshwar V, Soloway M (2001) Current bladder tumor tests: Does their projected utility fulfill clinical necessity? J Urol 165:1067-1077
21. Lopez VM, Galan JA, Fernandez-Suarez A et al (2003) Usefulness of tissue polypeptide antigen in the follow-up of bladder cancer. Urology 62:243-248
22. Lotan Y, Roehrborn CG (2003) Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analysis. Urology 61:109-118
23. Lougue-Sorgho LC, Cisse R, Kagone M et al (2002) Radiography and ultrasonography in the management of bladder tumors: 71 cases at the National Hospital Center of Yalgado Ouedraogo (Burkina Faso). Bull Soc Pathol Exot 95:244-247
24. Moll R, Franke W, Schiller DL et al (1982) The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24
25. Morrissey JH (1981) Silver stain in polyacrylamide gels. A modified procedure with enhanced uniform sensitivity. Anal Biochem 177:307-310
26. Moyad MA (2003) Bladder cancer prevention. Part I: What do I tell my patients about lifestyle changes and dietary supplements? Curr Opin Urol 13:363-378
27. Nichols RC, Sweetser MG, Mahmood SK (2000) Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder. Int J Cancer 90:281-286
28. Pariente JL, Bordenave L, Jacob F et al (2000) Analytical and prospective evaluation of urinary cytokeratin 19 fragment in bladder cancer. J Urol 163(4):1116-1119
29. Sarosdy MF, deVere White RW, Soloway MS et al (1995) Results of multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 154(2):379-383
30. Simon MA, Lokeshwar VB, Soloway MS (2003) Current bladder cancer tests: unnecessary or beneficial? Crit Rev Oncol Hematol 47:91-107
31. Siracusano S, Niccolini B, Knez R et al (2005) The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine. Eur Urol 47(3):327-333
32. Southgate J, Harnden P (1999) Cytokeratin 20: A new marker for early detection of bladder cell carcinoma. J Urol 162:501-502
33. Southgate J, Harnden P, Trejdosiewicz LK (1999) Cytokeratin expression patterns in normal and malignant urothelium: A review of the biological and diagnostic implications. Histol Histopathol 14:657-664
34. Stampfer DS, Capinito GA, Kodriguez-Villanueva J et al (1998) Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J Urol 159(2):394-398
35. Sudstrom BE, Stigbrand TI (1994) Cytokeratins and tissue polypeptide antigen. Int J Biol Markers 9:102-108
36. Tinzl M, Marberger M (2003) Urinary markers for detecting bladder cancer. EAU Update Series 1:64-70
37. Towbin H, Stachlin T, Gordou J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets; procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354
38. Tsihlias J, Grossman HB (2000) The utility of fibrinl/fibrinogen degradation products in superficial bladder cancer. Urol Clin North Am 27:39-46
39. Walker L, Liston TGL, Loyd-Davies RW (1993) Does flexible cystoscopy miss more tumours than rod-lens examination? Br J Urol 72:449-450
40. Wiener HG, Vooijs GP, van't Hof-Grootenboer B (1993) Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 37:163-169